HU Hai-tao, XU Xue-qin, SHEN Xiao-jun. Effect of Gegen Tongmaiyin on Preventing Atherosclerosis by Down-regulating BIP Protein Expression[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(1): 150-153.
DOI:
HU Hai-tao, XU Xue-qin, SHEN Xiao-jun. Effect of Gegen Tongmaiyin on Preventing Atherosclerosis by Down-regulating BIP Protein Expression[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(1): 150-153. DOI: 10.13422/j.cnki.syfjx.2015010150.
Effect of Gegen Tongmaiyin on Preventing Atherosclerosis by Down-regulating BIP Protein Expression
Objective: To study the influence of Gegen Tongmaiyin on vascular smooth muscle cells proliferation and immunoglobulin heavy chain binding protein (BIP) expression of endoplasmic endoplasmicreticulum stress gene in homocysteine-induced rabbits
and to explore its preventive mechanism on atherosclerosis. Method: Thirty rabbits were randomly divided into five groups:normal group
high-fat diet model group
rosuvastatin group (1 mg·kg-1·d-1)
low-and high-dose Gegen Tongmaiyin group (5
10 g·kg-1·d-1). Each group was given the corresponding diet and drug. After nine weeks
the serum levels of total cholesterol (TC)
triglycerides (TG)
low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol (HDL) were detected by enzymatic assays. Pathological change and BIP expression of vascular were detected. Result: Compared to high-fat diet model group
plasma TC
TG
LDL in rosuvastatin group and Gegen Tongmaiyin group were decreased
while plasma HDL was increased with significant difference (P<0.05
P<0.01). Compared to high-fat diet model group
BIP expression was down-regulated in rosuvastatin group
low-and high-dose Gegen Tongmaiyin group with significant difference (P<0.05
P<0.01). Pathological result indicated that Gegen Tongmaiyin could inhibited the development of atherosclerosis. Conclusion: Gegen Tongmaiyin could prevente atherosclerosis
which is related to the regulation of BIP expression.
Clinical Research of How Gegen Tongmaiyin Downregulating Plasma NF-B to Prevent Atherosclerosis
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Related Author
ZHANG Yan
SUN Jie
WANG Tan
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine